Literature DB >> 23546717

Light transmission aggregometry.

Juan Pablo Frontroth1.   

Abstract

Laboratory testing of platelet function is essential for the diagnosis of several congenital and acquired platelet disorders. Moreover, it is increasingly being utilized to monitor the efficacy of antiplatelet therapy. Light transmission platelet aggregation is the most useful in vitro test of platelet function currently available, and it is still the gold standard to detect platelet disorders and to initiate a more precise characterization.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23546717     DOI: 10.1007/978-1-62703-339-8_17

Source DB:  PubMed          Journal:  Methods Mol Biol        ISSN: 1064-3745


  7 in total

Review 1.  The Use of Thromboelastography in Percutaneous Coronary Intervention and Acute Coronary Syndrome in East Asia: A Systematic Literature Review.

Authors:  Ou Xu; Jan Hartmann; Yi-Da Tang; Joao Dias
Journal:  J Clin Med       Date:  2022-06-24       Impact factor: 4.964

2.  Microfludic platforms for the evaluation of anti-platelet agent efficacy under hyper-shear conditions associated with ventricular assist devices.

Authors:  Annalisa Dimasi; Marco Rasponi; Filippo Consolo; Gianfranco B Fiore; Danny Bluestein; Marvin J Slepian; Alberto Redaelli
Journal:  Med Eng Phys       Date:  2017-08-30       Impact factor: 2.242

3.  Effect of prediabetes on asprin or clopidogrel resistance in patients with recent ischemic stroke/TIA.

Authors:  Weili Jia; Qian Jia; Yumei Zhang; Xingquan Zhao; Yongjun Wang
Journal:  Neurol Sci       Date:  2020-11-11       Impact factor: 3.307

4.  Predictors of thrombotic complications and mass effect exacerbation after pipeline embolization: The significance of adenosine diphosphate inhibition, fluoroscopy time, and aneurysm size.

Authors:  Radoslav Raychev; Satoshi Tateshima; Fernando Vinuela; Jim Sayre; Reza Jahan; Nestor Gonzalez; Viktor Szeder; Gary Duckwiler
Journal:  Interv Neuroradiol       Date:  2015-11-03       Impact factor: 1.610

Review 5.  Platelets: still a therapeutical target for haemostatic disorders.

Authors:  Reinaldo Barros Geraldo; Plínio Cunha Sathler; André Luiz Lourenço; Max Seidy Saito; Lucio M Cabral; Pabulo Henrique Rampelotto; Helena Carla Castro
Journal:  Int J Mol Sci       Date:  2014-10-07       Impact factor: 5.923

6.  Ticagrelor induces paraoxonase-1 (PON1) and better protects hypercholesterolemic mice against atherosclerosis compared to clopidogrel.

Authors:  Hasseri Halim; Decha Pinkaew; Preedakorn Chunhacha; Patuma Sinthujaroen; Perumal Thiagarajan; Ken Fujise
Journal:  PLoS One       Date:  2019-06-26       Impact factor: 3.240

7.  Massive image-based single-cell profiling reveals high levels of circulating platelet aggregates in patients with COVID-19.

Authors:  Masako Nishikawa; Hiroshi Kanno; Yuqi Zhou; Ting-Hui Xiao; Takuma Suzuki; Yuma Ibayashi; Jeffrey Harmon; Shigekazu Takizawa; Kotaro Hiramatsu; Nao Nitta; Risako Kameyama; Walker Peterson; Jun Takiguchi; Mohammad Shifat-E-Rabbi; Yan Zhuang; Xuwang Yin; Abu Hasnat Mohammad Rubaiyat; Yunjie Deng; Hongqian Zhang; Shigeki Miyata; Gustavo K Rohde; Wataru Iwasaki; Yutaka Yatomi; Keisuke Goda
Journal:  Nat Commun       Date:  2021-12-09       Impact factor: 14.919

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.